Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
16.5M
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
29.8M
-
Shares change
-
-2.07M
-
Total reported value, excl. options
-
$59.9M
-
Value change
-
-$5.4M
-
Put/Call ratio
-
0.09
-
Number of buys
-
34
-
Number of sells
-
-46
-
Price
-
$2.01
Significant Holders of RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) as of Q3 2024
123 filings reported holding RAPT - RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2024.
RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.8M shares
.
Largest 10 shareholders include FMR LLC (5.24M shares), VANGUARD GROUP INC (3.16M shares), Column Group LLC (2.68M shares), BlackRock, Inc. (2.5M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (1.73M shares), D. E. Shaw & Co., Inc. (1.05M shares), MILLENNIUM MANAGEMENT LLC (960K shares), ACADIAN ASSET MANAGEMENT LLC (842K shares), FEDERATED HERMES, INC. (800K shares), and TWO SIGMA ADVISERS, LP (705K shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.